Company intelligence / Profile preview

Shaanxi Yisaier Biotechnology

Ownership: Private
Development stage: Other

Overview

Shaanxi Yisaier Biotechnology is a high-tech enterprise based in Xi'an, China, specializing in the research, development, and clinical application of advanced cell therapies. The company focuses on two primary pillars: immune cell therapy, including CAR-T and NK cells for oncology, and stem cell technology for regenerative medicine and anti-aging. Yisaier operates a comprehensive cell bank and state-of-the-art GMP-standard laboratory facilities to support its pipeline of therapeutic candidates and personalized health management services. Their business model integrates R&D, cell storage, and clinical transformation to address refractory diseases and promote precision medicine.

Therapeutic areas: OncologyRheumatologyOther
Modalities: CAR-T cell therapyNK cell therapyStem cell therapyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on Shaanxi Yisaier Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shaanxi Yisaier Biotechnology.